The aspartate metabolism pathway

the Achilles’ heel of Mycobacterium tuberculosis?

  • Michael Jonathan Institut Bio Scientia International Indonesia, Jakarta, Indonesia
  • Bobby Prabowo Sulistyo Institut Bio Scientia Internasional Indonesia, Jakarta, Indonesia
Keywords: Mycobacterium tuberculosis, aspartate metabolism, antituberculosis, drug discovery


Recent research has been conducted to find potential new avenues of drug discovery for treating tuberculosis infection. This endless “arms race” is due to the ability of the bacteria to develop resistance towards the already established antibiotic regimen. Various pathways within Mycobacterium tuberculosis are being studied extensively to open new possibilities in drug development. One of which is the aspartate metabolism pathway. This amino acid pathway is proven to be pivotal for the survival of M. tuberculosis both in vitro and in vivo. Furthermore, this pathway also is absent in humans, making it a very promising candidate for further research and development in drug discovery. However, inhibitors against this pathway are not yet available as most suggested inhibitors against the various enzymes within this pathway only made it until the in-silico stage while few studies managed to synthesize their suggested inhibitors and had tested its anti-tuberculosis activity. This review will discuss said attempts in suggesting inhibitors against the critical enzymes that work within this pathway. The inhibitors that are reviewed in this paper are both synthetic and derived from natural products. The multitude of inhibitors proposed and the various enzymes that they are able to inhibit proved that this pathway has potential that is yet to be explored further.


Download data is not yet available.

Author Biographies

Michael Jonathan, Institut Bio Scientia International Indonesia, Jakarta, Indonesia

Department of Biomedicine, Institut Bio Scientia International Indonesia

Bobby Prabowo Sulistyo, Institut Bio Scientia Internasional Indonesia, Jakarta, Indonesia

Department of Biomedicine, Institut Bio Scientia Internasional Indonesia


Ajijur, R., Salman, A., & Khan, M. (2021). Combinatorial Design to Decipher Novel Lead Molecule against Mycobacterium tuberculosis. Biointerface Research in Applied Chemistry, 11, 12993–13004.
Anand, P., & Chandra, N. (2014). Characterizing the pocketome of Mycobacterium tuberculosis and application in rationalizing polypharmacological target selection. Scientific Reports, 4, 6356.
Berney, M., Berney-Meyer, L., Wong, K.-W., Chen, B., Chen, M., Kim, J., Wang, J., Harris, D., Parkhill, J., Chan, J., Wang, F., & Jacobs, W. R. (2015). Essential roles of methionine and S -adenosylmethionine in the autarkic lifestyle of Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences, 112(32), 10008–10013.
Cashel, M., D. R. Gentry, V. H. Hernandez, and D. Vinella. (1996). The stringent response, p. 1458-1496. In F. C. Neidhardt et al. (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed., vol. 1. ASM Press, Washington, D.C.
Chaton, C. T., Rodriguez, E. S., Reed, R. W., Li, J., Kenner, C. W., & Korotkov, K. V. (2019). Structural analysis of mycobacterial homoserine transacetylases central to methionine biosynthesis reveals druggable active site. Scientific Reports, 9, 20267.
Daffé, M., Quémard, A., & Marrakchi, H. (2017). Mycolic Acids: From Chemistry to Biology. In O. Geiger (Ed.), Biogenesis of Fatty Acids, Lipids and Membranes (pp. 1–36). Springer International Publishing.
Du, X., Li, Y., Xia, Y.-L., Ai, S.-M., Liang, J., Sang, P., Ji, X.-L., & Liu, S.-Q. (2016). Insights into Protein–Ligand Interactions: Mechanisms, Models, and Methods. International Journal of Molecular Sciences, 17(2), 144.
Gualerzi, C. O., Brandi, L., Caserta, E., Teana, A. L., Spurio, R., Tomšic, J., & Pon, C. L. (2000). Translation Initiation in Bacteria. In The Ribosome (pp. 475–494). John Wiley & Sons, Ltd.
Hasenoehrl, E. J., Rae Sajorda, D., Berney-Meyer, L., Johnson, S., Tufariello, J. M., Fuhrer, T., Cook, G. M., Jacobs, W. R., & Berney, M. (2019). Derailing the aspartate pathway of Mycobacterium tuberculosis to eradicate persistent infection. Nature Communications, 10(1), 4215.
Jansen, R. S., Mandyoli, L., Hughes, R., Wakabayashi, S., Pinkham, J. T., Selbach, B., Guinn, K. M., Rubin, E. J., Sacchettini, J. C., & Rhee, K. Y. (2020). Aspartate aminotransferase Rv3722c governs aspartate-dependent nitrogen metabolism in Mycobacterium tuberculosis. Nature Communications, 11(1), 1960.
Khan, S., Somvanshi, P., Bhardwaj, T., Mandal, R., Dar, S., Wahid, M., Jawed, A., Lohani, M., Khan, M., Areeshi, M., & Haque, S. (2017). Aspartate‐β‐semialdeyhyde dehydrogenase as a potential therapeutic target of Mycobacterium tuberculosis H37Rv: Evidence from in‐silico elementary mode analysis of biological network model. Journal of Cellular Biochemistry, 119.
Kumar, R., Garg, P., & Bharatam, P. V. (2015). Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors. Journal of Biomolecular Structure and Dynamics, 33(5), 1082–1093.
Meng, J., Yang, Y., Xiao, C., Guan, Y., Hao, X., Deng, Q., & Lu, Z. (2015). Identification and Validation of Aspartic Acid Semialdehyde Dehydrogenase as a New Anti-Mycobacterium Tuberculosis Target. International Journal of Molecular Sciences, 16(10), 23572–23586.
Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., & Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19(14), 1639–1662.<1639::AID-JCC10>3.0.CO;2-B
Neidhardt, F. C. (1996). Escherichia Coli and Salmonella: Cellular and Molecular Biology (2nd ed.). AMerican Society for Microbiology.
Parthiban, B. D., Saxena, S., Chandran, M., Jonnalagadda, P. S., Yadav, R., Srilakshmi, R. R., Perumal, Y., & Dharmarajan, S. (2016). Design and Development of Mycobacterium tuberculosis Lysine ɛ -Aminotransferase Inhibitors for Latent Tuberculosis Infection. Chemical Biology & Drug Design, 87(2), 265–274.
Parveen, N., & Cornell, K. A. (2011). Methylthioadenosine/S-adenosylhomocysteine nucleosidase, a critical enzyme for bacterial metabolism. Molecular Microbiology, 79(1), 7–20.
Paulson, T. (2013). Epidemiology: A mortal foe. Nature, 502(7470), S2–S3.
Pavelka, M. S., & Jacobs, W. R. (1996). Biosynthesis of diaminopimelate, the precursor of lysine and a component of peptidoglycan, is an essential function of Mycobacterium smegmatis. Journal of Bacteriology, 178(22), 6496–6507.
Pyle, M. M. (1947). Relative numbers of resistant tubercle bacilli in sputa of patients before and during treatment with streptomycin. Proceedings of the Staff Meetings. Mayo Clinic, 22(21), 465–473.
Rajender, K., Ratnika, S., Purvi, S., Ipsita, R., Inder, P. S., P., V. B., Rupinder, T., & Prabha, G. (2016). Biological Evaluation of Small Molecule Inhibitors of Mtb-ASADH Enzyme. Letters in Drug Design & Discovery, 13(7), 587–590.
Sakamoto, H., Lee, S., Ishizuka, A., Hinoshita, E., Hori, H., Ishibashi, N., Komada, K., Norizuki, M., Katsuma, Y., Akashi, H., & Shibuya, K. (2019). Challenges and opportunities for eliminating tuberculosis – leveraging political momentum of the UN high-level meeting on tuberculosis. BMC Public Health, 19(1), 76.
Schaeffer, L. (2008). The Role of Functional Groups in Drug–Receptor Interactions. In The Practice of Medicinal Chemistry (pp. 359–378). Elsevier.
Shafiani, S., Sharma, P., Vohra, R. M., & Tewari, R. (2005). Cloning and characterization of aspartate-beta-semialdehyde dehydrogenase from Mycobacterium tuberculosis H37 Rv. Journal of Applied Microbiology, 98(4), 832–838.
Usha, V., Lloyd, A. J., Roper, D. I., Dowson, C. G., Kozlov, G., Gehring, K., Chauhan, S., Imam, H. T., Blindauer, C. A., & Besra, G. S. (2016). Reconstruction of diaminopimelic acid biosynthesis allows characterisation of Mycobacterium tuberculosis N -succinyl-L,L-diaminopimelic acid desuccinylase. Scientific Reports, 6(1), 23191.
Viola, R. E. (2001). The Central Enzymes of the Aspartate Family of Amino Acid Biosynthesis. Accounts of Chemical Research, 34(5), 339–349.
World Health Organization. (2018). Global tuberculosis report 2018. World Health Organization.
World Health Organization. (2020). Global tuberculosis report 2020. World Health Organization.
Yang, Q., Yu, K., Yan, L., Li, Y., Chen, C., & Li, X. (2011). Structural view of the regulatory subunit of aspartate kinase from Mycobacterium tuberculosis. Protein & Cell, 2(9), 745–754.
Zhan, L., Wang, J., Wang, L., & Qin, C. (2020). The correlation of drug resistance and virulence in Mycobacterium tuberculosis. Biosafety and Health, 2(1), 18–24.
Life Science for Health and Wellbeing